Amazon is taking a big step to make Eli Lilly’s new weight-loss pill, Foundayo, easier to get for millions of Americans. The tech giant will stock the medication at kiosks inside its One Medical clinics and offer same-day delivery in many U.S. Cities.

Amazon’s Pharmacy Push Expands with Foundayo

Amazon Pharmacy is growing beyond traditional home delivery by placing kiosks inside some of its One Medical primary care clinics to stock Foundayo, Eli Lilly’s latest GLP-1 weight-loss pill. The move aims to cut down barriers for patients who need quick, convenient access to their prescriptions.

Foundayo, approved recently, is a daily oral pill designed to help with weight loss, a market that’s heating up fast. Unlike injectable options, this pill doesn’t need refrigeration, making it easier for Amazon to store and distribute at kiosks, according to Tanvi Patel, vice president at Amazon Pharmacy. "No need for cold storage is what allows for broader access and for them to be stored safely in a kiosk for dispensing," Patel said.

Right now, about half of Amazon Pharmacy customers in the U.S. Can get Foundayo delivered the same day they order it, with plans to expand coverage to more areas. For all customers, Amazon guarantees delivery within four days.

Pricing and Access Options

Foundayo’s price varies depending on insurance coverage and dose. For customers paying out of pocket, the lowest dose starts at $149 per month, while higher doses can run between $299 and $349 monthly.

Those with insurance covering GLP-1 weight-loss drugs might pay as little as $25 a month.

Besides Amazon Pharmacy, customers can buy Foundayo through other channels like telehealth providers Ro and Weight Watchers or directly from Eli Lilly’s own LillyDirect platform. Amazon Pharmacy fulfills prescriptions from LillyDirect and offers delivery options in partnership with other services.

Both Eli Lilly and Novo Nordisk, the maker of the competing Wegovy pill, are betting that daily oral weight-loss medications will attract people who want to avoid injections or who have faced stigma around weight-loss treatments.

Kiosk Expansion and Healthcare Integration

Amazon first introduced its pharmacy kiosks last year to sell common medications like antibiotics, asthma inhalers, and blood pressure drugs. The idea was to reduce shipping costs and improve access by placing these kiosks in convenient locations.

Currently, Amazon has kiosks at five One Medical clinics in Los Angeles, but plans to roll them out across the country. The expansion depends on state regulations, but Amazon is clearly aiming for a nationwide footprint.

One Medical, Amazon’s primary and urgent care business, charges a $199 annual subscription. Patients without a membership can still book appointments and use the kiosks, making the service accessible to a broad range of customers.

The Growing Market for Oral Weight-Loss Drugs

The weight-loss drug market has been booming since the introduction of GLP-1 receptor agonists, which help regulate appetite and blood sugar. Novo Nordisk launched its oral Wegovy pill earlier this year, and Amazon has been delivering GLP-1 medications since 2021.

Amazon’s expansion of Foundayo availability highlights how tech companies are getting more involved in healthcare, blending traditional pharmacy services with telehealth and in-person clinics. Their strategy aims to make prescriptions easy to get and affordable, especially for drugs that have high demand and complicated distribution needs.

Amazon’s approach could shake up the pharmaceutical landscape by cutting wait times and providing multiple buying options. That might pressure other drugmakers and pharmacies to speed up their own delivery and access services.

Implications for Patients and the Industry

For patients, faster delivery and local kiosks mean less hassle getting weight-loss medication, which could improve adherence and outcomes. The stigma that often surrounds weight-loss treatments might soften as pills become easier to obtain discreetly.

For Amazon, this is a smart play to grow its healthcare footprint and leverage its logistics network. The company is betting that convenient access to popular medications will keep customers loyal and expand its pharmacy business.

At the same time, Amazon is testing how well it can navigate healthcare regulations and insurance complexities, which differ by state and drug type. Expanding kiosks nationwide won’t be simple, but the company seems committed to making it happen.

Meanwhile, other players like Novo Nordisk and telehealth providers will watch closely. Amazon’s success with Foundayo could push competitors to boost their own digital pharmacy offerings and delivery speed.

Right now, the weight-loss pill market is still young, but the demand shows no sign of slowing. Amazon is positioning itself to be a go-to source for these new treatments, blending tech, logistics, and healthcare in a way few others can match.

Related Articles

Amazon’s move to stock Eli Lilly’s Foundayo at in-clinic kiosks and expand same-day delivery could reshape how Americans get access to weight-loss medications. The company’s push into healthcare is gathering pace — and the race to win over patients and providers is just getting started.